Amenitop TM was developed by Matsushita Electric Industrial Co., Ltd. It is an inorganic material originally developed to prevent bacterial contamination on the surface of appliances such as telephone and facsimile machines, and consists of silica gel micmspheres containing silverthiosulfate complex (AT-l). It has a coating layer of tetraethoxysilanet that enables gradual release of AT-1 on the surface. AT-1 showed bactericidal effect on various kinds of bacteria such as E. co S. aumus, methicillin resistant S. aumus (MRSA). So, we examined antiviral effect of AT-1 on several kinds of viruses such as human immunodeficiency virus-1 (HIV-1, JMH-1), herpes simplex virus type-2 (HSV-2, G strain), measles virus (MV, Nagahata strain) and polio virus type-1 (PV, Sabin vaccine type 1). AT-1 was extracted into phosphate buffered saline (PBS) from Amenitop TM at 37 C.for 30 min to obtain pure AT-I. The extracted AT-1 was stored at -80 C until use. HIV-1 was propagated in MT-4 cells. HSV-2, MV and PV were propagated in Veto cells. Stock viruses were prepared from the culture supematant fluids by low speed centrifugation and stored at -80 C until use.
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An aliquot of 500 I1 of the stock virus and AT-1 was mixed and incubated at 37 C, 22 C or 4 C for a given time. AT-1 was removed from the mixture by centrifugation using Centrisart (Sartorius Co. Ltd., cut off M.W. 20000) after the incubation. Then, the mixture was supplemented with 1 ml of PBS. Virus infectivity was measured using microplates by observing cytopathic effect.
AT-1 reduced infectivity of HIV-1103 TCID5o/ml in 30 min at 37 C. The inactivating effect of AT-1 on HIV-1 was temperature-dependent and it failed to inactivate HIV-1 at 4 C. Further, we examined the inhibiting effect of AT-1 on HIV-1 multiplication. Twelve nM of AT-1 in the culture medium inhibited multiplication of HIV-1 during 4 to 7 days culture after infection at multiplicity of infection 0.001 without any cytotoxicity.
Likewise, AT-1 inactivated MV104 TCID5o/ml at 37 C in 30 min. Temperature dependency of the inactivating effect of AT-1 was the same as in the case of HIV-1 and it failed to inactivate MV at 4 C even after 3 hours incubation. Inactivation of HSV-2 and PV with AT-1 was similarly examined.
AT-1 inactivated HSV-2 106 TCID5o/mI. However, PV did not show any reduction in infectivity.
The results suggest membrane-destroying effect of 
